Public trial registry of the CCC-Munich

Trial ADRIATIC

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ADRIATIC
World
Full title
:

Eine randomisierte, doppelblinde, placebokontrollierte, multizentrische, internationale Phase-III-Studie zu Durvalumab oder Durvalumab und Tremelimumab als Konsolidierungsbehandlung für Patienten mit kleinzelligem Lungenkrebs im begrenzten Stadium, die nach gleichzeitiger Radiochemotherapie keine Progression zeigten (ADRIATIC)

World
Description
:
Unknown
Eye
Primary endpoints
:

Eye
Secondary endpoints
:

World
EudraCT number
:
World
DRKS number
:
Unknown
World
NCT number
:
World
ISRCTN number
:
Unknown
World
Responsible organization
:
Asklepios Klinik Gauting, Telefon: 089857914001
Eye
Legal basis
:
AMG interventional
Eye
Registered by
:
MUELLER-SI5 ()
Indications
Classification Code Description
ICD-10-GM C34.- Bösartige Neubildung der Bronchien und der Lunge
- lung cancers
In-/Exclusion (Edit)
Eye
Criterion for Inclusion
:
Unknown
Eye
Criterion for exclusion
:
Unknown
Trial design
World
IIT (sponsored by KUM)
:
No
Eye
Sponsor status
:
Commercial
World
Trial type
:
Interventional
World
Blinding type
:
Double blinded
World
Phase
:
III
Eye
Center design
:
Polycentric
Eye
Treatment arms count
:
Unknown
Eye
Sample size
:
730
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
World
Institutional review board - reference number
:
World
PEI - vote
:
Unknown
World
PEI - reference number
:
World
BfArM - vote
:
Unknown
World
BfArM - reference number
:
Initiiation & lock
World
Date of lock (planned / actual)
:
2024-05-10 / Unknown
Recruitment
Eye
Time period (from / to)
:
Unknown / Unknown
Therapy
World
Therapy line
:
Unknown
Eye
Therapy Category
:
World
Therapy
:

Tumorboards (Edit)
Eye
:
Dermatology Endocrinology Gastrointestinal
Gynecological Hematology KHT
Liver Lung Neurooncological
Pediatry Ortho. / Sarkoma Urological
Additionally involved centers (Edit)
Eye
:
Pharmacy Radiology
Institut für Labormedzin Transfusiology
Radiotherapy Nuclear medicine
Participants
Function Prename Surname Organization
World Principal Investigator NIELS REINMUTH Keine Organisationseinheit angegeben Magnifier